Logotipo do repositório
 

Publicação:
Amyloid-polysaccharide interfacial coacervates as therapeutic materials

dc.contributor.authorPeydayesh, Mohammad
dc.contributor.authorKistler, Sabrina
dc.contributor.authorZhou, Jiangtao
dc.contributor.authorLutz-Bueno, Viviane
dc.contributor.authorVictorelli, Francesca Damiani
dc.contributor.authorMeneguin, Andréia Bagliotti [UNESP]
dc.contributor.authorSpósito, Larissa [UNESP]
dc.contributor.authorBauab, Tais Maria [UNESP]
dc.contributor.authorChorilli, Marlus [UNESP]
dc.contributor.authorMezzenga, Raffaele
dc.contributor.institutionETH Zurich
dc.contributor.institutionPaul Scherrer Institute PSI
dc.contributor.institutionUniversidade Estadual Paulista (UNESP)
dc.date.accessioned2023-07-29T13:49:36Z
dc.date.available2023-07-29T13:49:36Z
dc.date.issued2023-12-01
dc.description.abstractCoacervation via liquid-liquid phase separation provides an excellent opportunity to address the challenges of designing nanostructured biomaterials with multiple functionalities. Protein-polysaccharide coacervates, in particular, offer an appealing strategy to target biomaterial scaffolds, but these systems suffer from the low mechanical and chemical stabilities of protein-based condensates. Here we overcome these limitations by transforming native proteins into amyloid fibrils and demonstrate that the coacervation of cationic protein amyloids and anionic linear polysaccharides results in the interfacial self-assembly of biomaterials with precise control of their structure and properties. The coacervates present a highly ordered asymmetric architecture with amyloid fibrils on one side and the polysaccharide on the other. We demonstrate the excellent performance of these coacervates for gastric ulcer protection by validating via an in vivo assay their therapeutic effect as engineered microparticles. These results point at amyloid-polysaccharides coacervates as an original and effective biomaterial for multiple uses in internal medicine.en
dc.description.affiliationETH Zurich Department of Health Sciences and Technology
dc.description.affiliationETH Zurich Department of Materials
dc.description.affiliationPaul Scherrer Institute PSI
dc.description.affiliationDepartment of Drugs and Medicines School of Pharmaceutical Sciences São Paulo State University, Sao Paulo
dc.description.affiliationDepartment of Biological Sciences School of Pharmaceutical Sciences São Paulo State University, Sao Paulo
dc.description.affiliationUnespDepartment of Drugs and Medicines School of Pharmaceutical Sciences São Paulo State University, Sao Paulo
dc.description.affiliationUnespDepartment of Biological Sciences School of Pharmaceutical Sciences São Paulo State University, Sao Paulo
dc.identifierhttp://dx.doi.org/10.1038/s41467-023-37629-z
dc.identifier.citationNature Communications, v. 14, n. 1, 2023.
dc.identifier.doi10.1038/s41467-023-37629-z
dc.identifier.issn2041-1723
dc.identifier.scopus2-s2.0-85151692538
dc.identifier.urihttp://hdl.handle.net/11449/248639
dc.language.isoeng
dc.relation.ispartofNature Communications
dc.sourceScopus
dc.titleAmyloid-polysaccharide interfacial coacervates as therapeutic materialsen
dc.typeArtigopt
dspace.entity.typePublication
relation.isDepartmentOfPublication5004bcab-94af-4939-b980-091ae9d0a19e
relation.isDepartmentOfPublicatione214da1b-9929-4ae9-b8fd-655e9bfeda4b
relation.isDepartmentOfPublication.latestForDiscovery5004bcab-94af-4939-b980-091ae9d0a19e
unesp.author.orcid0000-0002-6265-3811[1]
unesp.author.orcid0000-0003-4248-2207[3]
unesp.author.orcid0000-0002-5739-2610[10]
unesp.departmentCiências Biológicas - FCFpt
unesp.departmentFármacos e Medicamentos - FCFpt

Arquivos